Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled DiabetesJunichi Matsubara, Hisao Ogawa, Eiichi Akiyama et al.|Circulation Journal|2013Cited by 199
Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 YearsKoji Sato, Hisao Ogawa, Kenichi Tsujita et al.|Journal of the American Heart Association|2013Cited by 159
Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery DiseaseKeisuke Ohba, Hisao Ogawa, Yasuhiro Nagayoshi et al.|Journal of the American Heart Association|2012Cited by 110